[{"edinetCode":"E32854","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":34.0,"averageTemporaryStaff":2.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":28938000.0,"sharesOwendPercent":0.7608,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/3\/15","stockCode":4596,"accountingYear":"第３期（自　2017年１月１日　至　2017年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":20.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/3\/28","stockCode":4596,"accountingYear":"第４期（自　2018年１月１日　至　2018年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/10","stockCode":4596,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":16137000.0,"sharesOwendPercent":0.3815,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/8\/9","stockCode":4596,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/14","stockCode":4596,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":12.0,"averageTemporaryStaff":3.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":8740591000.0,"currentAssets":8177448000.0,"fixedAsset":null,"tangibleFixedAssets":53176000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":663509000.0,"currentLiabilities":505440000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":842595000.0,"capitalSurplus":26160540000.0,"accumulatedEarnings":-17110873000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-3418451000.0,"depreciationAndCashflowFromOperatingActivities":45949000.0,"cashFlowFromInvestingActivities":4593732000.0,"cashFlowFromFinancialActivities":462903000.0,"changesInCashAndCashEquivalents":1607494000.0,"列1":"asr","submitDate":"2020\/3\/27","stockCode":4596,"accountingYear":"第５期（自　2019年１月１日　至　2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":7993971000.0,"currentAssets":7805880000.0,"fixedAsset":null,"tangibleFixedAssets":41733000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":662112000.0,"currentLiabilities":535428000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":842595000.0,"capitalSurplus":26174372000.0,"accumulatedEarnings":-17824199000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-663996000.0,"depreciationAndCashflowFromOperatingActivities":10944000.0,"cashFlowFromInvestingActivities":1261205000.0,"cashFlowFromFinancialActivities":-41955000.0,"changesInCashAndCashEquivalents":527447000.0,"列1":"q1r","submitDate":"2020\/5\/14","stockCode":4596,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":14738000.0,"sharesOwendPercent":0.3484,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":7325087000.0,"currentAssets":7121011000.0,"fixedAsset":null,"tangibleFixedAssets":78467000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":584679000.0,"currentLiabilities":463563000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":842595000.0,"capitalSurplus":26186631000.0,"accumulatedEarnings":-18364324000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1204456000.0,"depreciationAndCashflowFromOperatingActivities":21994000.0,"cashFlowFromInvestingActivities":1477986000.0,"cashFlowFromFinancialActivities":-76890000.0,"changesInCashAndCashEquivalents":121163000.0,"列1":"q2r","submitDate":"2020\/8\/13","stockCode":4596,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":6919876000.0,"currentAssets":6757016000.0,"fixedAsset":null,"tangibleFixedAssets":73046000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":629128000.0,"currentLiabilities":541543000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":973309000.0,"capitalSurplus":26325310000.0,"accumulatedEarnings":-18982725000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1742508000.0,"depreciationAndCashflowFromOperatingActivities":32910000.0,"cashFlowFromInvestingActivities":195051000.0,"cashFlowFromFinancialActivities":145765000.0,"changesInCashAndCashEquivalents":-1549011000.0,"列1":"q3r","submitDate":"2020\/11\/13","stockCode":4596,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":8.0,"averageTemporaryStaff":4.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":6691936000.0,"currentAssets":6417023000.0,"fixedAsset":null,"tangibleFixedAssets":220228000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":698857000.0,"currentLiabilities":506651000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1148650000.0,"capitalSurplus":26523421000.0,"accumulatedEarnings":-19548297000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2248704000.0,"depreciationAndCashflowFromOperatingActivities":45380000.0,"cashFlowFromInvestingActivities":340394000.0,"cashFlowFromFinancialActivities":453779000.0,"changesInCashAndCashEquivalents":-1658581000.0,"列1":"asr","submitDate":"2021\/3\/29","stockCode":4596,"accountingYear":"第６期（自　2020年１月１日　至　2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":6548590000.0,"currentAssets":6303307000.0,"fixedAsset":null,"tangibleFixedAssets":220941000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":745486000.0,"currentLiabilities":570047000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1245138000.0,"capitalSurplus":26649038000.0,"accumulatedEarnings":-20244851000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-622867000.0,"depreciationAndCashflowFromOperatingActivities":14408000.0,"cashFlowFromInvestingActivities":1884792000.0,"cashFlowFromFinancialActivities":159286000.0,"changesInCashAndCashEquivalents":1542272000.0,"列1":"q1r","submitDate":"2021\/5\/13","stockCode":4596,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":14835000.0,"sharesOwendPercent":0.3259,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":5874488000.0,"currentAssets":5644551000.0,"fixedAsset":null,"tangibleFixedAssets":206071000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":659805000.0,"currentLiabilities":494314000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1269981000.0,"capitalSurplus":26700918000.0,"accumulatedEarnings":-20899295000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1283419000.0,"depreciationAndCashflowFromOperatingActivities":29014000.0,"cashFlowFromInvestingActivities":2802383000.0,"cashFlowFromFinancialActivities":171814000.0,"changesInCashAndCashEquivalents":1810887000.0,"列1":"q2r","submitDate":"2021\/8\/12","stockCode":4596,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0},{"edinetCode":"E32854","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":5378174000.0,"currentAssets":5152240000.0,"fixedAsset":null,"tangibleFixedAssets":202046000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":631332000.0,"currentLiabilities":485218000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":1308902000.0,"capitalSurplus":26739035000.0,"accumulatedEarnings":-21478869000.0,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1925933000.0,"depreciationAndCashflowFromOperatingActivities":43819000.0,"cashFlowFromInvestingActivities":3525764000.0,"cashFlowFromFinancialActivities":210108000.0,"changesInCashAndCashEquivalents":1964352000.0,"列1":"q3r","submitDate":"2021\/11\/12","stockCode":4596,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E32854","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"無","capital3":1,"settlementDate":"2022\/12\/31","submitterName":"窪田製薬ホールディングス株式会社","submitterNameEnglish":"Kubota Pharmaceutical Holdings Co., Ltd.","submitterNameKana":"クボタセイヤクホールディングスカブシキカイシャ","location":"千代田区霞が関３丁目７番１号","industory":"医薬品","corporateNumber":3010000000000.0}]